vs
Side-by-side financial comparison of GDEV Inc. (GDEV) and USANA HEALTH SCIENCES INC (USNA). Click either name above to swap in a different company.
USANA HEALTH SCIENCES INC is the larger business by last-quarter revenue ($226.2M vs $119.9M, roughly 1.9× GDEV Inc.). GDEV Inc. runs the higher net margin — 13.9% vs 0.1%, a 13.8% gap on every dollar of revenue. On growth, GDEV Inc. posted the faster year-over-year revenue change (13.3% vs -10.0%).
GDEV Inc. is a gaming and entertainment holding company. It is a publicly traded company listed on the Nasdaq stock exchange, headquartered in Limassol, Cyprus. The holding was evolved in June 2023 from a video game company Nexters, founded in 2014, one of the top five independent mobile game companies in Europe. Subsidiaries of GDEV include Nexters Studio, which operates offices in Cyprus, Armenia, and Kazakhstan, as well as Cubic Games, Royal Ark, Game Gears and Light Hour Games. The compan...
Usana Health Sciences, Inc., or USANA, is an American multi-level marketing company based in Salt Lake City, Utah. As of 2021, Usana was the 14th largest direct-selling company in the world by revenue. The company manufactures most of its nutritional products, dietary supplements, and skincare products at a Salt Lake City facility. Its products are sold in 24 countries via a network of independent distributors.
GDEV vs USNA — Head-to-Head
Income Statement — Q2 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $119.9M | $226.2M |
| Net Profit | $16.6M | $180.0K |
| Gross Margin | — | 78.2% |
| Operating Margin | 15.5% | 1.7% |
| Net Margin | 13.9% | 0.1% |
| Revenue YoY | 13.3% | -10.0% |
| Net Profit YoY | 13.0% | -74.0% |
| EPS (diluted) | $0.90 | $-0.10 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $226.2M | ||
| Q3 25 | — | $213.7M | ||
| Q2 25 | $119.9M | $235.8M | ||
| Q1 25 | — | $249.5M | ||
| Q4 24 | — | $213.6M | ||
| Q3 24 | — | $200.2M | ||
| Q2 24 | $105.8M | $212.9M | ||
| Q2 23 | $114.9M | — |
| Q4 25 | — | $180.0K | ||
| Q3 25 | — | $-6.5M | ||
| Q2 25 | $16.6M | $9.7M | ||
| Q1 25 | — | $9.4M | ||
| Q4 24 | — | $4.5M | ||
| Q3 24 | — | $10.6M | ||
| Q2 24 | $14.7M | $10.4M | ||
| Q2 23 | $19.5M | — |
| Q4 25 | — | 78.2% | ||
| Q3 25 | — | 77.2% | ||
| Q2 25 | — | 78.7% | ||
| Q1 25 | — | 79.0% | ||
| Q4 24 | — | 82.0% | ||
| Q3 24 | — | 80.4% | ||
| Q2 24 | — | 81.1% | ||
| Q2 23 | — | — |
| Q4 25 | — | 1.7% | ||
| Q3 25 | — | 0.6% | ||
| Q2 25 | 15.5% | 7.1% | ||
| Q1 25 | — | 6.3% | ||
| Q4 24 | — | 3.8% | ||
| Q3 24 | — | 7.8% | ||
| Q2 24 | 14.4% | 8.4% | ||
| Q2 23 | 12.9% | — |
| Q4 25 | — | 0.1% | ||
| Q3 25 | — | -3.1% | ||
| Q2 25 | 13.9% | 4.1% | ||
| Q1 25 | — | 3.8% | ||
| Q4 24 | — | 2.1% | ||
| Q3 24 | — | 5.3% | ||
| Q2 24 | 13.9% | 4.9% | ||
| Q2 23 | 17.0% | — |
| Q4 25 | — | $-0.10 | ||
| Q3 25 | — | $-0.36 | ||
| Q2 25 | $0.90 | $0.52 | ||
| Q1 25 | — | $0.49 | ||
| Q4 24 | — | $0.23 | ||
| Q3 24 | — | $0.56 | ||
| Q2 24 | $0.81 | $0.54 | ||
| Q2 23 | $0.99 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $41.6M | $158.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-129.4M | — |
| Total Assets | $210.2M | $742.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $158.4M | ||
| Q3 25 | — | $145.3M | ||
| Q2 25 | $41.6M | $151.3M | ||
| Q1 25 | — | $179.6M | ||
| Q4 24 | — | $181.8M | ||
| Q3 24 | — | $364.9M | ||
| Q2 24 | $50.8M | $332.4M | ||
| Q2 23 | $68.6M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | $528.1M | ||
| Q2 25 | $-129.4M | $531.1M | ||
| Q1 25 | — | $529.8M | ||
| Q4 24 | — | $532.1M | ||
| Q3 24 | — | $533.1M | ||
| Q2 24 | $-118.7M | $512.2M | ||
| Q2 23 | $-135.8M | — |
| Q4 25 | — | $742.9M | ||
| Q3 25 | — | $726.6M | ||
| Q2 25 | $210.2M | $734.5M | ||
| Q1 25 | — | $746.6M | ||
| Q4 24 | — | $748.2M | ||
| Q3 24 | — | $671.3M | ||
| Q2 24 | $282.8M | $631.4M | ||
| Q2 23 | $302.2M | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
